HANX

HANX is connecting the major life stages of women’s health for a 100,000+ strong community, with gynae-designed sexual and reproductive health products including prescription treatments and content. Founded by former Goldman Sachs investment banking professional Farah Kabir and gynaecology and obstetrics expert Dr Sarah Welsh, it offers direct-to-consumer women's wellness essentials, with a core pleasure focused product line including sensitive condoms and lubricant, and a bestselling toy, Cindy. Inspired by the evolving needs of the HANX community at every life stage, the product line has expanded to include natural, nutritionist-approved supplements to support the pregnancy to postpartum journey, menopausal symptoms and libido in women. Alongside this, HANX also offers a pioneering same-day-dispatch pharmacy service, discreetly delivering hormonal contraception on subscription, plus the morning after pill and intimate care treatments. In September 2024, HANX became the first women's health brand in the UK to launch safe, effective GLP-1 medication, Mounjaro (tirzepatide) and Wegovy (semaglutide), as part of a new weight management programme to support women to reach their life goals, for the long-term. Alongside its e-commerce focus, HANX has partnered with all major UK retailers to revolutionise women's health and wellness aisles. The only challenger brand on shelf, HANX products can be found in 2,000+ high street stores, including Boots, Sainsbury’s, Tesco and WHSmith. As part of its targeted expansion strategy, HANX recently launched DTC operations in the US, in line with major consumer demand, with plans for further global presence to follow. HANX has received widespread press coverage, with titles including Forbes, BBC, Vogue, Cosmopolitan, The Independent and Forbes.